BioAge Labs, Inc. — Director's Dealing 2024

Sep 27, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioAge Labs, Inc. (BIOA)
CIK: 0001709941
Period of Report: 2024-09-25

Reporting Person: ENRIGHT PATRICK G (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-09-27	Common Stock	C	1310589	—	Acquired	1310589	Indirect
2024-09-27	Common Stock	P	400000	$18	Acquired	1710589	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-25	Stock Option (Right to Buy)	$18	A	15000	Acquired	2034-09-24	Common Stock (15000)	Direct
2024-09-27	Series D Preferred Stock	$	C	5848637	Disposed		Common Stock (1310589)	Indirect

Footnotes

F1: Pursuant to the Issuer's Restated Certificate of Incorporation, upon closing of the Issuer's initial public offering of its Common Stock, each share of Series D Convertible Preferred Stock automatically converted into shares of Common Stock at a ratio of 1-for-0.224084614. The securities have no expiration date.

F2: These shares are directly held by Longitude Venture Partners IV, L.P ("LVP IV"). Longitude Capital Partners IV, LLC ("LCP IV") is the general partner of LVP IV and may be deemed to exercise voting and investment discretion with respect to securities held by LVP IV. The reporting person and Ms. Juliet Tammenoms Bakker serve as the managing members of LCP IV and may be deemed to share voting and investment discretion with respect to securities held directly by LVP IV. Each of LCP IV, Mr. Enright, and Ms. Tammenoms Bakker disclaims beneficial ownership of such securities and this report shall not be deemed an admission that any of them is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, except to the extent of their respective pecuniary interests therein.

F3: The entire option award shall vest on the earlier of: (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date.